Newbridge Financial Services Group’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.1K Buy
11,400
+6,800
+148% +$30K 0.01% 501
2026
Q1
$16.6K Buy
+4,600
New +$15.9K ﹤0.01% 687
2025
Q3
Sell
-19
Closed -$259 1342
2025
Q2
$259 Hold
19
﹤0.01% 1259
2025
Q1
$103 Hold
19
﹤0.01% 1010
2024
Q4
$94 Sell
19
-3,081
-99% -$16.2K ﹤0.01% 1107
2024
Q3
$16.2K Buy
+3,100
New +$17.9K 0.01% 380
2024
Q2
Sell
-1,000
Closed -$10.3K 1171
2024
Q1
$10.3K Hold
1,000
﹤0.01% 764
2023
Q4
$8.29K Buy
+1,000
New +$7.19K ﹤0.01% 778
2021
Q4
Sell
-4,000
Closed -$25K 1486
2021
Q3
$25K Buy
+4,000
New +$34.1K 0.02% 597

Other funds holding LFMD

Newbridge Financial Services Group's LFMD Position: Q2 2026 in Review

Newbridge Financial Services Group increased its LifeMD (LFMD) stake by 148% in Q2 2026, buying an estimated $30K and bringing the position to 11,400 shares worth $47.1K. The position accounts for 0.01% of the portfolio, ranked #501.

Newbridge Financial Services Group first reported a position in LFMD in Q3 2021 and has held it in 9 quarters since. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Newbridge Financial Services Group held 11,400 shares of LifeMD worth $47.1K as of Q2 2026.
  • Newbridge Financial Services Group bought 6,800 LifeMD shares in Q2 2026, an estimated $30K.
  • LifeMD made up 0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #501 holding.
  • Newbridge Financial Services Group first reported a position in LifeMD in Q3 2021 and has held it in 9 quarters since.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.